A retrospective case control study to compare the efficacy of detrusor injections of onabotulinum toxin A 300 U or 200 U versus abobotulinum toxin A 750 U in patients with neurogenic detrusor overactivity
Latest Information Update: 29 Jan 2018
Price :
$35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Detrusor instability; Overactive bladder
- Focus Therapeutic Use
- 16 Sep 2016 Results presented at the 46th Annual Meeting of the International Continence Society
- 04 Jul 2016 New trial record.